OLMA Research and Charts

OLMA - Olema Pharmaceuticals inc Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-01-03)

Last 5.89	Change ⇑ +0.32 (+5.75%)	Volume 1,330,133
	Open 5.59	High 6.00	Low 5.48

8EMA (Daily) 5.99	40EMA (Daily) 8.15	50EMA (Daily) 8.61	STO (Daily) 11.143	MACD Hist (Daily) 0.051
8EMA (Weekly) 7.788	40EMA (Weekly) 10.54	50EMA (Weekly) 10.64	STO (Weekly) 14.005	MACD Hist (Weekly) -1.264


Company Profile
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.